Drugs / Polyethylene glycol + ascorbate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04598880 | Nov 2020 → Apr 2024 | colonic disorder | Parc de Salut Mar | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene glycol + ascorbate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04598880 ↗ |
| Route | Oral | “Pleinvue® is administered orally in 2 doses (3 sachets) as per SmPC within the previous 18 hours to colonoscopy intervention.” NCT04598880 ↗ |